Paulo Maciag
About Paulo Maciag
Paulo Maciag is a Clinical Development Leader at Bristol Myers Squibb with extensive experience in oncology, immunology, and cancer research.
Title and Current Role at Bristol Myers Squibb
Paulo Maciag is currently serving as the Clinical Development Leader at Bristol Myers Squibb in New Jersey, United States. He holds a pivotal role in the clinical development sector, bringing his extensive experience in oncology, immunology, and rheumatology into his current responsibilities.
Previous Role at AbbVie
From 2015 to 2020, Paulo Maciag worked at AbbVie in the Greater Chicago Area, Illinois. He served as the Senior Medical Director, Oncology, where he contributed significantly to oncology programs. His five-year tenure at AbbVie highlights his substantial involvement in developing and overseeing oncology treatments.
Experience at Takeda Pharmaceuticals
Paulo Maciag held the position of Medical Director, Immunology & Rheumatology at Takeda Pharmaceuticals from 2013 to 2015. During his two years in Deerfield, Illinois, he worked on key immunology and rheumatology projects, leveraging his expertise to advance Takeda's medical initiatives in these areas.
Academic Background and Research
Paulo Maciag has a robust academic background in biochemistry, genetics, and medicine. He earned his Ph.D. in Biochemistry from Universidade de São Paulo (1998-2002). He also holds an M.S. in Genetics (1994-1998) and an M.D. in Medicine (1987-1993) from Universidade Federal do Paraná. His academic foundation has been instrumental in his research and professional roles, particularly in cancer immunology and immunotherapy.
International Research Experience
Paulo Maciag has accumulated extensive international research experience, notably through his work at the Ludwig Institute for Cancer Research in São Paulo, Brazil. From 1998 to 2002, he served as a Scientist, furthering research in cancer domains. This international perspective has enriched his subsequent roles in the biomedical field.
Tenure at Bristol-Myers Squibb and Other Key Roles
Paulo Maciag rejoined Bristol Myers Squibb in 2020 as the Clinical Development Leader, after a previous stint from 2009 to 2013 as the Associate Medical Director, Immunosciences in Princeton, New Jersey. Prior to his current role, he also worked at Advaxis, Inc., from 2006 to 2009 as Senior Scientist, Cancer Immunology & Immunotherapy, and held a post-doctoral fellowship at the University of Pennsylvania School of Medicine from 2002 to 2006, focusing on cancer immunology and immunotherapy.